Your browser doesn't support javascript.
loading
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals.
Maeda, Kenji; Amano, Masayuki; Uemura, Yukari; Tsuchiya, Kiyoto; Matsushima, Tomoko; Noda, Kenta; Shimizu, Yosuke; Fujiwara, Asuka; Takamatsu, Yuki; Ichikawa, Yasuko; Nishimura, Hidehiro; Kinoshita, Mari; Matsumoto, Shota; Gatanaga, Hiroyuki; Yoshimura, Kazuhisa; Oka, Shin-Ichi; Mikami, Ayako; Sugiura, Wataru; Sato, Toshiyuki; Yoshida, Tomokazu; Shimada, Shinya; Mitsuya, Hiroaki.
Afiliación
  • Maeda K; Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan. kmaeda@ri.ncgm.go.jp.
  • Amano M; Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan.
  • Uemura Y; Center of Clinical Sciences, NCGM, Tokyo, Japan.
  • Tsuchiya K; AIDS Clinical Center, NCGM, Tokyo, Japan.
  • Matsushima T; Sysmex Corporation, Hyogo, Japan.
  • Noda K; Sysmex Corporation, Hyogo, Japan.
  • Shimizu Y; Center of Clinical Sciences, NCGM, Tokyo, Japan.
  • Fujiwara A; Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan.
  • Takamatsu Y; Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan.
  • Ichikawa Y; JCHO Kumamoto General Hospital, Kumamoto, Japan.
  • Nishimura H; JCHO Kumamoto General Hospital, Kumamoto, Japan.
  • Kinoshita M; JCHO Kumamoto General Hospital, Kumamoto, Japan.
  • Matsumoto S; JCHO Kumamoto General Hospital, Kumamoto, Japan.
  • Gatanaga H; AIDS Clinical Center, NCGM, Tokyo, Japan.
  • Yoshimura K; Tokyo Metropolitan Institute for Public Health, Tokyo, Japan.
  • Oka SI; AIDS Clinical Center, NCGM, Tokyo, Japan.
  • Mikami A; Center of Clinical Sciences, NCGM, Tokyo, Japan.
  • Sugiura W; Center of Clinical Sciences, NCGM, Tokyo, Japan.
  • Sato T; Sysmex Corporation, Hyogo, Japan.
  • Yoshida T; Sysmex Corporation, Hyogo, Japan.
  • Shimada S; JCHO Kumamoto General Hospital, Kumamoto, Japan.
  • Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan. hmitsuya@hosp.ncgm.go.jp.
Sci Rep ; 11(1): 22848, 2021 11 24.
Article en En | MEDLINE | ID: mdl-34819514
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Vacuna BNT162 Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Vacuna BNT162 Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido